PubMed 32 Connell ND: Reg ulation of a stationary phase promoter

PubMed 32. Connell ND: Reg ulation of a stationary phase promoter, Pmcb, in Escherichia coli. PhD thesis Harvard University, Cambridge, Mass 1989. 33. Tentler S: Gene regulation within the flhB operon of Escherichia coli. MS thesis University of Illinois, Chicago 1994. 34. Cui Y, Chatterjee A, Yang H, Chatterjee K: Regulatory Network Controlling Extracellular Proteins in Erwinia carotovora subsp. carotovora : FlhDC, the Master Regulator of Flagellar Genes, Activates rsmB Regulatory RNA Production by Affecting gacA and hexA ( lrhA ) Expression. J Bacteriol 2008, 190:4610–4623.CrossRefPubMed 35. Prüss BM, Matsumura EPZ-6438 in vivo P: A regulator of the flagellar of Escherichia coli, flhD, also affects

cell division. J Bacteriol 1996, 178:668–674.PubMed 36. Prüss BM, Matsumura P: Cell cycle regulation of flagellar genes. J Bacteriol 1997, 179:5602–5604.PubMed 37. Gantotti BV, Kindle KL, Beer SV: Transfer of the drug-resistance transposon Tn 5 to Erwinia herbicola and the induction of insertion Mutations. Curr Microbiol 1981, 6:417–425.CrossRef 38. Reusch RN, Hiske TW, Sadoff HL: Poly-beta-hydroybutyrate membrane structure and its relationship to genetic transformability in Escherichia coli. J Bacteriol 1986, 168:553–562.PubMed 39. Bolivar CP-868596 solubility dmso F, Rodriguez RL, Greene PJ, Betlach MC, Heyneker HL, Boyer HW: Construction and characterization on of new cloning vehicles II. A multipurpose cloning system. Gene 1977, 2:95–113.CrossRefPubMed

Authors’ contributions YC participated in the bacteriocin analysis and construction

of the null GSI-IX mw alleles of the fliC and flhA genes. DC conceived the study, participated in its design, and corrected the manuscript. All authors read and approved the final manuscript.”
“Background The inflammatory bowel diseases (IBD), Crohn disease and ulcerative colitis, are relatively common chronic disorders considered to develop due to an aberrant immune response to intestinal microbes in a genetically susceptible host [1]. Human data and murine models both implicate the involvement of luminal bacteria in IBD pathogenesis. For example, inflammation is induced BCKDHA by direct delivery of fecal material into non-inflamed bowel loops in susceptible individuals [2] and diversion of feces results in distal improvement in mucosal inflammation [3]. In addition, most of the genes associated with susceptibility to IBD, including NOD2/CARD15, Atg16L1 and IRGM encode proteins involved in host-microbial interactions [4]. Further support for the involvement of microbes in the pathogenesis of IBD is based on the observation that colitis does not occur in most gene knock-out models of IBD when animals are reared in germ-free conditions [5, 6]. Recent advances in molecular techniques have identified a reduction in the phyla Firmicutes and Bacteroidetes in IBD patients [7]. Although several organisms have been proposed as a cause of IBD, there is still no compelling evidence that any one specific microbe is the etiologic agent.

Comments are closed.